Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3975-3988
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3975
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3975
Table 5 Observed adverse events according to common terminology criteria for adverse events grading, n (%)
| Adverse event | TACE/HAIC + S-1, n = 55 | TACE/HAIC, n = 60 | P value |
| Liver injury | 0.243 | ||
| Grades 1-2 | 28 (50.9) | 23 (38.3) | |
| Grades 3-4 | 27 (49.1) | 37 (61.7) | |
| Vomiting | 0.478 | ||
| Grades 1-2 | 23 (41.8) | 29 (48.3) | |
| Grades 3-4 | 1 (1.8) | 0 (0) | |
| Abdominal pain | 0.820 | ||
| Grades 1-2 | 37 (67.3) | 37 (61.7) | |
| Grades 3-4 | 10 (18.2) | 13 (21.7) | |
| Fever | 0.277 | ||
| Grades 1-2 | 45 (81.8) | 44 (73.3) | |
| Grades 3-4 | 0 (0) | 0 (0) | |
| Leukopenia | 0.465 | ||
| Grades 1 | 2 (3.6) | 4 (6.7) | |
| Grades 2-4 | 0 (0) | 0 (0) | |
| Thrombocytopenia | 0.793 | ||
| Grade 1 | 9 (16.4) | 11 (18.3) | |
| Grade 2 | 7 (12.7) | 7 (11.7) | |
| Grade 3 | 0 (0) | 1 (1.7) | |
| Grade 4 | 0 (0) | 0 (0) | |
| Anemia | 0.220 | ||
| Grade 1 | 7 (12.7) | 15 (25.0) | |
| Grade 2 | 2 (3.6) | 5 (8.3) | |
| Grade 3 | 1 (1.8) | 1 (1.7) | |
| Grade 4 | 0 (0) | 0 (0) |
- Citation: Guo JH, Liu SX, Gao S, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu P, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, Zhu X. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World J Gastroenterol 2020; 26(27): 3975-3988
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3975.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3975